Apolipoprotein C1 (APOC1) as a Novel Diagnostic and Prognostic Biomarker for Lung Cancer: A Marker Phase I Trial

Thoracic Cancer - Australia
doi 10.1111/1759-7714.12117
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Serum Pleiotrophin as a Diagnostic and Prognostic Marker for Small Cell Lung Cancer

Journal of Cellular and Molecular Medicine
Molecular MedicineCell Biology
2019English

Plasma Mesothelin as a Novel Diagnostic and Prognostic Biomarker in Colorectal Cancer

Journal of Cancer
Oncology
2017English

CDK1 Serves as a Potential Prognostic Biomarker and Target for Lung Cancer

Journal of International Medical Research
BiochemistryMedicineCell Biology
2020English

Comment on “circSMARCA5 Functions as a Diagnostic and Prognostic Biomarker for Gastric Cancer”

Disease Markers
BiochemistryMedicineClinical BiochemistryMolecular BiologyGenetics
2019English

LAPTM4B Is a Novel Diagnostic and Prognostic Marker for Lung Adenocarcinoma and Associated With Mutant EGFR

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

Dikkopf-1 as a Novel Serologic and Prognostic Biomarker for Lung and Esophageal Carcinomas

Cancer Research
Cancer ResearchOncology
2007English

PD23-04 THE POTENTIAL UTILITY OF CHEMOKINE CXCL1 (GROα) AS a NOVEL DIAGNOSTIC AND PROGNOSTIC MARKER FOR BLADDER CANCER

Journal of Urology
Urology
2015English

Nuclear-Enriched Abundant Transcript 1 as a Diagnostic and Prognostic Biomarker in Colorectal Cancer

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2015English

LncRNA as a Diagnostic and Prognostic Biomarker in Bladder Cancer: A Systematic Review and Meta-Analysis

OncoTargets and Therapy
OncologyPharmacology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy